SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
Showing session: reset
PREVENTION 2020: AGENTS, OPTIONS, AND OUTCOMES
- Sort by:
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
8 of
8
|
BIC/FTC/TAF POSTEXPOSURE PROPHYLAXIS PROTECTS MACAQUES AGAINST RECTAL SHIV INFECTION (ABSTRACT
87)
Elena Bekerman
Gilead Sciences Inc, Foster City, CA, USA
ON-DEMAND HIV POSTEXPOSURE PROPHYLAXIS BY TAF/EVG VAGINAL INSERTS IN MACAQUES (ABSTRACT
88)
Charles Dobard
CDC, atlanta, GA, USA
WEEKLY ORAL ISLATRAVIR PROVIDES EFFECTIVE PEP AGAINST IV CHALLENGE WITH SIVMAC251 (ABSTRACT
89)
Jay Grobler
Merck & Co, West Point, PA, USA
PHASE I PLACEBO-CONTROLED SAFETY, PK, AND PD STUDY OF MB66 ANTI-HIV AND ANTI-HSV FILM (ABSTRACT
90)
Susan Cu-Uvin
The MIriam Hospital, Providence, RI, USA
NEAR-PERFECT ACCURACY OF A REAL-TIME URINE TENOFOVIR TEST COMPARED TO LAB-BASED ELISA (ABSTRACT
91)
Matthew A Spinelli
University of California San Francisco, San Francisco, CA, USA
LONGER-TERM SAFETY OF F/TAF AND F/TDF FOR HIV PREP: DISCOVER TRIAL WEEK-96 RESULTS (ABSTRACT
92)
Onyema Ogbuagu
Yale School of Medicine, New Haven, CT, USA
INITIATING PREP DURING ACUTE HIV INFECTION: WHAT IS THE RISK FOR ARV DRUG RESISTANCE? (ABSTRACT
93)
Donn J Colby
Thai Red Cross AIDS Research Centre, Seattle, WA, USA
PEPFAR DREAMS INTERVENTION AMONG ADOLESCENT GIRLS AND YOUNG WOMEN IN RAKAI, UGANDA (ABSTRACT
94)
Hadijja Nakawooya
Rakai Health Sciences Program, KALISIZO TOWN, Uganda
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
8 of
8
|
